Quick links

Leading With an Eye on the Future of Care

The Fresenius Kabi Executive Leadership Team

Every vision needs a forward-looking leadership team with the power to inspire and push boundaries while being close to all those actively helping realize its implementation. Our Executive Leadership Team is continually striving to advance our shared vision through sound growth strategies, investment in future markets, and personal interaction throughout our global sites. Leading by example with respect and responsibility is at the core all our management’s activities.

Pierluigi Antonelli

President and CEO of Fresenius Kabi

As President and CEO of Fresenius Kabi, Pierluigi Antonelli is at the forefront in helping create and lead the next step in our company's strategic roadmap. During his distinguished career, he has held leading positions at numerous international corporations, including Novartis Oncology, Sandoz, Merck & Co, Bristol-Myers Squibb, McKinsey & Company and as CEO of Angelini Pharma. He holds an MBA from Kellogg School of Management and a degree in Business and Economics from L.U.I.S.S.

At a glance
  • CEO of Fresenius Kabi since March 2023 
  • Over 25 years of management experience 
  • Deep operational expertise in product development and launch of new products in key international markets
Pierluigi Antonelli

Andreas Duenkel

Chief Financial Officer & Chief Compliance Officer

Andreas Duenkel’s experience in international finance leadership spans continents and corporations. Before joining the Management Board, he was Chief Finance Officer for our North American region. As a certified Chartered Accountant, Andreas has honed his strategic business and financial skills with leadership positions at Siemens Healthineers AG, Siemens AG, and at Ernst & Young and Arthur Andersen in the UK.

At a glance
  • CFO of Fresenius Kabi since June 2022 
  • Over 20 years in senior financial roles across healthcare businesses 
  • Extensive expertise in finance transformations 
Andreas Duenkel

Helio Fujita

Chief Human Resources Officer

Helio Fujita brings over 20 years of senior HR and business leadership experiences across various industries and geographies. Previous to joining Fresenius Kabi, he was Senior Vice President Human Resources at Novartis, with key focus on HR transformation, leadership development as well as HR operations and business partnering. Helio Fujita has held management positions in several large companies worldwide (Brazil, Belgium, Germany, Singapore, Switzerland). In this way, he has developed a deep understanding of different work cultures and businesses and an extensive expertise in driving large-scale transformations to shape modern and innovative HR organizations. 

At a glance
  • CHRO of Fresenius Kabi since September 2024
  • In-depth experience in in building and leading HR organizations in international companies
  • Core expertise in driving business and HR transformations 
Helio Fujita

Dr. Marc-Alexander Mahl

President Pharma, Nutrition and Sustainability 

Marc Mahl brings a comprehensive portfolio to the Management Board with extensive experience in the pharmaceutical and nutrition industry. His focus is on strategy, development, production, M&A, and reorganization management. Before his current position, he served as Head of Business Unit Generics and IV Fluids EU & RoW of Fresenius Kabi. Marc is a trained physician, specializing in transfusion medicine and holds an eMBA degree from INSEAD. 

At a glance
  • Working at Fresenius since 2001 
  • Gained broad advocacy experience from his role as past President of Medicines for Europe in Brussels
  • Extensive management experience and leadership role in the development and operations of generic drugs and nutrition 
Dr. Marc-Alexander Mahl

Dr. Christian Hauer

President MedTech 

Christian Hauer, became Member of the Fresenius Kabi Management Board in January 2013 and President of Fresenius Kabi MedTech in January 2022 after serving several years as President Medical Devices and President Transfusion Medicine and Cell Therapies. Before joining Fresenius Kabi in 2012 as Head of GBS Medical Devices, he worked for more than 13 years for Drägerwerk AG, where he held various management positions including VP Services USA, President global Sales & Marketing, President Dräger Medical and member of the Executive team of Drägerwerk AG. Christian Hauer holds a master’s degree in business administration and industrial engineering (Wirtschaftsingenieur) and a PhD in industrial engineering from the Technical University Hamburg-Harburg.

At a glance
  • First joined Fresenius in 2012 
  • Held various leading positions in MedTech
  • Pivotal role in successful transformation of the Transfusion Medicine and Cell Therapies business
Dr. Christian Hauer

Dr. Sang-Jin Pak

President Biopharma

Sang-Jin Pak joined Fresenius Kabi as President Biopharma on June 1, 2024. He is a medical doctor with more than 25 years of experience in healthcare and pharmaceutical industry, patient care, commercialization, marketing and sales, talent management, organizational development, and new product launches. During his career, Sang-Jin has held leading positions as General Manager at AstraZeneca Korea and GSK Germany and most recently as EVP and Head of the Global Commercial Division at Samsung Bioepis.

At a glance

  • President of Biopharma and member of the Fresenius Kabi board since June 2024
  • Extensive leadership experience with cross-functional and cross-cultural teams
  • Track record of business transformation and commercial turn-around delivery
Dr. Michael Schönhofen

Marc Crouton

President Region Europe

Marc Crouton has taken a major role in the successful development of Fresenius Kabi as member of the Management Board since 1998, with responsibilities on various key sectors and geographies. After managing and developing subsidiaries in France, Spain, Portugal and Italy, he was responsible for the fast international growth of the company in Latin America, Africa, Middle East and Asia including China, through strategic acquisitions and their integration.

At a glance:
  • Working at Fresenius since 1992
  • Joined the Fresenius Kabi Management Board in 1998 as President of Global Fluid Therapy Division
  • President of Region Europe since April 2023
Marc Crouton

Ulf Jansson

Executive Vice President Region Asia Pacific

Ulf Jansson flourishes a genuine global leadership experience in Fresenius Kabi. Having been working abroad for more than 15 years, Ulf has taken C-suites positions to lead the business in regions such as Eastern Europe, Middle East and Africa as well as Asia Pacific. His focus is on strategic development, M&A, organization optimization and development. Ulf holds a master’s degree in Business Administration and Industrial Engineering from the Karlsruhe University of Technology.

At a glance
  • First joined Fresenius in 1999
  • Held various international leadership roles in different geographic regions
  • Pivotal role in strategizing business in Region Asia Pacific for profitable growth 
Ulf Jansson

Alain Mollard

Executive Vice President Region International

Alain Mollard started more than 30 years ago in the French sales organization being for 3 years the General manager of Fresenius Medical care France. In 2001 he moves to Barcelona being the General manager of Fresenius Kabi Spain and EVP of a small region including Spain, Portugal, Greece, and Turkey. In 2003 He takes the responsibility of a new region including Iberia and Latin America developing the region with some important acquisitions. Year after year his region increased the numbers of countries with France, Italy, UK, Belgium, Netherland, Switzerland and Africa. He holds an eMBA from HEC.

At a glance
  • Joined Fresenius in 1992
  • Sales & Marketing background
  • Business knowledge of many countries
Alain Mollard

Arunesh Verma

President Region U.S.

Arunesh Verma is a global pharmaceutical leader with deep expertise leading pharmaceutical businesses and functions across North America, Asia and Australia. He currently serves as President, Region U.S., having joined Fresenius Kabi in 2024. Before joining Fresenius Kabi, Arun gained extensive experience in driving growth, scaling businesses through innovative commercial strategies, and building pharmaceutical pipelines. He has held roles of increasing responsibility at Cipla where he was CEO of North America, as well as Torrent Pharma, Sandoz, Dr. Reddy’s, and Novartis, where he began his career as a medical sales representative. Arun holds an MBA from Symbiosis Institute of Business Management, and a bachelor’s degree in pharmaceutical sciences, pharmacology and pharmaceutics from the University of Mumbai.

At a glance

  • President Region U.S. for Fresenius Kabi since July 2024
  • More than 20 years of commercial pharmaceutical management experience
  • Proven industry leader with previous senior roles on three continents
Arunesh Verma

Eduardo Montanha

Executive Vice President TechOps and Quality

Eduardo Montanha is a seasoned Pharmaceutical Operations professional with extensive expertise and global experience in leading manufacturing organizations. Before joining Fresenius Kabi, Eduardo held several leadership roles at multinational corporations, including Takeda, Sanofi, and Sandoz. He holds a degree in chemical engineering from the Federal University of Paraná, a post-graduate degree in industrial automation from the FEI University Center, and an MBA from the Getulio Vargas Foundation.

At a glance

  • Over 25 years of management experience
  • Extensive expertise in operational leadership within the pharmaceutical industry

Dr. Matthias Tyssen

Head of Corporate Development, Executive Vice President

Matthias Tyssen brings broad experience in leading and developing key businesses within Fresenius Kabi including our Nutrition, IV Fluids and IV Drugs business. His expertise spans from Portfolio and Project Management, Product and Business Development, Regulatory Affairs, to Marketing. Before joining Fresenius, Matthias gained experience in the Volkswagen Group leading inhouse consulting projects. Matthias holds a diploma degree in business administration and industrial engineering from University of Stuttgart and a Ph.D. in strategic management from EBS Business School.

At a glance

  • Joined Fresenius in 2014 
  • Broad management experience in leadership roles across different business units
  • Pivotal role in the US market entry with a full IV Fluids portfolio and localization of operations 
Matthias Tyssen